Prosecution Insights
Prosecution Insights
11 pending office actions • 9 art units • 11 examiners • 0 of 11 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (9%) |
| §112 only | 4 (36%) |
| Multi-statute (no §101) | 6 (55%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RUMP, RICHARD M | 1 | 74.6% | +20.1% |
| TSUI, YUNG-SHENG M | 1 | 66.5% | +7.2% |
| BONAPARTE, AMY C | 1 | 79.4% | +23.0% |
| PATEL, NIKETA I | 1 | 42.9% | +9.5% |
| WIECZOREK, MICHAEL P | 1 | 54.9% | +17.1% |
| GRASER, JENNIFER E | 1 | 76.5% | +23.6% |
| O DELL, DAVID K | 1 | 57.7% | +36.0% |
| STONEBRAKER, ALYSSA RAE | 1 | 56.9% | +50.4% |
| STOFFA, WYATT A | 1 | 79.5% | +23.1% |
| CHEN, STACY BROWN | 1 | 66.0% | +40.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18291554 | TOOL FOR CONTINUOUS INSERTION-DEPTH MONITORING FOR IMPLANTABLE LEAD | PATEL, NIKETA I | 38d overdue |
| 18552827 | Vaccine Compositions for Trypanosomatids | GRASER, JENNIFER E | 3d overdue |
| 17627953 | MUCIN ISOFORMS IN DISEASES CHARACTERIZED BY BARRIER DYSFUNCTION | BORGEEST, CHRISTINA M | 13d |
| 18690996 | FEEDING SYSTEM FOR FEEDING POWDER MATERIAL AND SYSTEM FOR CONTINUOUS PRODUCTION OF SOLID DOSAGE FORMS | TSUI, YUNG-SHENG M | 75d |
| 18576022 | METHOD FOR PRODUCING AN ORGANIC FUNCTIONALIZED INORGANIC SUBSTRATE | WIECZOREK, MICHAEL P | — |
| 18267231 | Cell-Based Therapeutics Targeting CD70 | STONEBRAKER, ALYSSA RAE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17761459 | HUMAN RESPIRATORY SYNCYTIAL VIRUS STRAIN AND ITS USE | CHEN, STACY BROWN | 17d overdue |
| 18265897 | CHARGED PARTICLE MICROSCOPY MEMS SAMPLE SUPPORT | STOFFA, WYATT A | 16d overdue |
| 18552827 | Vaccine Compositions for Trypanosomatids | GRASER, JENNIFER E | 3d overdue |
| 18276532 | QUINAZOLIN-4-ONE AND THIENO[2,3-D]PYRIMIDIN-4-ONE INHIBITORS OF ERBB4 (HER4) FOR USE IN THE TREATMENT OF CANCER | O DELL, DAVID K | 21d |
| 18701078 | AMMONIUM NITRATE PRODUCTION | RUMP, RICHARD M | — |
| 18688192 | Process for the Production of Levulinic Acid and Derivatives Thereof | BONAPARTE, AMY C | — |
| 18576022 | METHOD FOR PRODUCING AN ORGANIC FUNCTIONALIZED INORGANIC SUBSTRATE | WIECZOREK, MICHAEL P | — |
| 18267231 | Cell-Based Therapeutics Targeting CD70 | STONEBRAKER, ALYSSA RAE | — |
| Art Unit | Apps |
|---|---|
| 1684 | 1 |
| 3792 | 1 |
| 1773 | 1 |
| 1645 | 1 |
| 1621 | 1 |
| 1642 | 1 |
| 2881 | 1 |
| 1672 | 1 |
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18701078 | AMMONIUM NITRATE PRODUCTION | RUMP, RICHARD M | — | §112 | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18690996 | FEEDING SYSTEM FOR FEEDING POWDER MATERIAL AND SYSTEM FOR CONTINUOUS PRODUCTION OF SOLID DOSAGE FORMS | TSUI, YUNG-SHENG M | 1684 | §102§112 | Non-Final OA | 75d | Pending | Mar 11, 2024 |
| 18688192 | Process for the Production of Levulinic Acid and Derivatives Thereof | BONAPARTE, AMY C | — | §112 | Non-Final OA | — | Pending | Feb 29, 2024 |
| 18291554 | TOOL FOR CONTINUOUS INSERTION-DEPTH MONITORING FOR IMPLANTABLE LEAD | PATEL, NIKETA I | 3792 | §102§103§112 | Non-Final OA | 38d overdue | Pending | Jan 23, 2024 |
| 18576022 | METHOD FOR PRODUCING AN ORGANIC FUNCTIONALIZED INORGANIC SUBSTRATE | WIECZOREK, MICHAEL P | 1773 | §102§103 | Non-Final OA | — | Pending | Jan 02, 2024 |
| 18552827 | Vaccine Compositions for Trypanosomatids | GRASER, JENNIFER E | 1645 | §103§112 | Final Rejection | 3d overdue | Pending | Sep 27, 2023 |
| 18276532 | QUINAZOLIN-4-ONE AND THIENO[2,3-D]PYRIMIDIN-4-ONE INHIBITORS OF ERBB4 (HER4) FOR USE IN THE TREATMENT OF CANCER | O DELL, DAVID K | 1621 | §112 | Final Rejection | 21d | Pending | Aug 09, 2023 |
| 18267231 | Cell-Based Therapeutics Targeting CD70 | STONEBRAKER, ALYSSA RAE | 1642 | §102§103§112 | Non-Final OA | — | Pending | Jun 14, 2023 |
| 18265897 | CHARGED PARTICLE MICROSCOPY MEMS SAMPLE SUPPORT | STOFFA, WYATT A | 2881 | §103 | Final Rejection | 16d overdue | Pending | Jun 07, 2023 |
| 17761459 | HUMAN RESPIRATORY SYNCYTIAL VIRUS STRAIN AND ITS USE | CHEN, STACY BROWN | 1672 | §112 | Final Rejection | 17d overdue | Pending | Mar 17, 2022 |
| 17627953 | MUCIN ISOFORMS IN DISEASES CHARACTERIZED BY BARRIER DYSFUNCTION | BORGEEST, CHRISTINA M | 1675 | §103§112Other | Final Rejection | 13d | Pending | Jan 18, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial